“…Auvity and Tournier used metoclopramide as an in vivo P‐glycoprotein (P‐gp) test substrate in baboons to assess the effect of ethanol on this carrier as a component of the blood–brain barrier (BBB). Their finding is unequivocal: ethanol at plasma concentrations of 0.5–1.0 g/L has no effect, whereas coadministration of tariquidar, used as a reference P‐gp inhibitor, drastically increased metoclopramide distribution to the brain.…”